FDA Clears Teleflex Dialysis Catheter

Limerick, Pa.-based Teleflex has earned U.S. Food and Drug Administration 510(k) clearance for its Arrow Nextstep retrograde femoral length dialysis catheter which is designed for clinician ease of insertion and sustained high flow rates.

“Providing clinicians with the Arrow Nextstep femoral length catheters continues a series of new product introductions that demonstrates our commitment to enhance patient outcomes and improve ease of use for clinicians,” said Linda Beneze, president and general manager of Teleflex’s Specialty Division.

The Arrow Nextstep retrograde hemodialysis catheter is designed to take better advantage of the blood flow dynamics within the heart through its reversed port configuration, where the venous port resides in the superior vena cava and the arterial port in the right atrium, resulting in reduced recirculation and high flow rates. The Nextstep tip is designed for smooth, over-the-wire transitions during catheter insertions and exchanges.

Teleflex makes products for the critical care and surgical spaces.